Literature DB >> 12558110

A female with Coffin-Lowry syndrome and "cataplexy".

H Fryssira1, S Kountoupi, J P Delaunoy, L Thomaidis.   

Abstract

Coffin-Lowry syndrome (CLS) is an X-linked semidominant condition, caused by mutations in the gene encoding the ribosomal protein S6 kinase-2 (RSK-2), a growth factor regulating protein kinase, which is mapped to Xp 22.2. The syndrome is mainly seen in males. It is manifested by moderate to severe mental retardation and characteristic facial, hand and skeletal malformations. We present a female patient with fully manifested CLS, confirmed by molecular analysis, who experienced daily drop episodes, diagnosed as "cataplexy". The episodes were precipitated by emotional or auditory stimuli and were significantly reduced, by selective serotonine re-uptake inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12558110

Source DB:  PubMed          Journal:  Genet Couns        ISSN: 1015-8146


  4 in total

1.  Treatment of drop episodes in Coffin-Lowry syndrome.

Authors:  Sean O'Riordan; M Patton; F Schon
Journal:  J Neurol       Date:  2005-07-20       Impact factor: 4.849

Review 2.  Treatment paradigms for cataplexy in narcolepsy: past, present, and future.

Authors:  Todd J Swick
Journal:  Nat Sci Sleep       Date:  2015-12-11

3.  Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders.

Authors:  Lisa Hinz; Stephanie D Hoekstra; Kyoko Watanabe; Danielle Posthuma; Vivi M Heine
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

4.  De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females.

Authors:  Bernt Popp; Svein I Støve; Sabine Endele; Line M Myklebust; Juliane Hoyer; Heinrich Sticht; Silvia Azzarello-Burri; Anita Rauch; Thomas Arnesen; André Reis
Journal:  Eur J Hum Genet       Date:  2014-08-06       Impact factor: 4.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.